🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus 14mg real-world experience thread Page 3

Rybelsus 14mg real-world experience thread

mike_nyc Sat, Jun 6, 2026 at 1:42 AM 21 replies 520 viewsPage 3 of 5
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Jun 6, 2026 at 5:48 AM#11
anders_CPH said:
Read four things before the headline number.

Agreed, and subgroup analyses deserve particular suspicion. With enough subgroups something is significant by chance, and pre-registered subgroups are a different animal from ones found afterwards.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Correct me if the detail matters more than I have assumed.

33 6CarlaRPh_TPA, steph_laguna, fiona_glasgow and 30 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Jun 6, 2026 at 8:05 AM#12
sarah_TO said:
Worth adding that the tablet is taken daily, so a missed dose costs far less than a missed weekly injection.

Genuinely useful, thank you. I had the facts and not the framework. Adding it to my notes with a link back to this thread.

Last edited: Jun 6, 2026 at 1:05 PM
34 7ben_calgary, patPC_UT, Dr.DermMIA and 31 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Jun 6, 2026 at 10:21 AM#13
anders_CPH said:
Read four things before the headline number.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Jun 6, 2026 at 3:21 PM
35 8mike_nyc, VendorMark, COA_Karl and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Jun 6, 2026 at 12:38 PM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

36 9andrew_nyc, Dr.EndoEP, GraceAZ_72 and 33 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 6, 2026 at 2:55 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

37 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 34 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register